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Background: Surveillance data of antibiotic use are increasingly being used for benchmarking purposes, but there
is a lack of studies dealing with how hospital- and patient-related factors affect antibiotic utilization in hospitals. Our
objective was to identify factors that may contribute to differences in antibiotic use.
Methods: Based on pharmacy sales data (2006–2011), use of all antibiotics, all penicillins, and broad-spectrum
antibiotics was analysed in 22 Health Enterprises (HEs). Antibiotic utilization was measured in World Health
Organisation defined daily doses (DDDs) and hospital-adjusted (ha)DDDs, each related to the number of bed days
(BDs) and the number of discharges. For each HE, all clinical specialties were included and the aggregated data at
the HE level constituted the basis for the analyses. Fourteen variables potentially associated with the observed antibiotic
use – extracted from validated national databases – were examined in 12 multiple linear regression models, with four
different measurement units: DDD/100 BDs, DDD/100 discharges, haDDD/100 BDs and haDDD/100 discharges.
Results: Six variables were independently associated with antibiotic use, but with a variable pattern depending on the
regression model. High levels of nurse staffing, high proportions of short (<2 days) and long (>10 days) hospital stays,
infectious diseases being the main ICD-10 diagnostic codes, and surgical diagnosis-related groups were correlated with
a high use of all antibiotics. University affiliated HEs had a lower level of antibiotic utilization than other institutions in
eight of the 12 models, and carried a high explanatory strength. The use of broad-spectrum antibiotics correlated
strongly with short and long hospital stays. There was a residual variance (30%–50% for all antibiotics; 60%–70% for
broad-spectrum antibiotics) that our analysis did not explain.
Conclusions: The factors associated with hospital antibiotic use were mostly non-modifiable. By adjusting for these
factors, it will be easier to evaluate and understand observed differences in antibiotic use between hospitals.
Consequently, the inter-hospital differences can be more confidently acted upon. The residual variation is presumed
to largely reflect prescriber-related factors.
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In working towards rational use of antibiotics in hospi-
tals, one needs to establish and maintain a suitable sys-
tem for surveillance of antibiotic use [1]. However, the
surveillance commonly applied is hampered by meth-
odological pitfalls that impede the interpretation of the
surveillance findings [2].* Correspondence: jobhau57@gmail.com
1Department of Infectious Diseases, Oslo University Hospital Trust, Oslo,
Norway
Full list of author information is available at the end of the article
© 2014 Haug et al.; licensee BioMed Central. T
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.First, antibiotic utilization measurement using the
number of patient bed days (BDs) as denominator may
give results and interpretations that differ from those
obtained when the number of patient discharges is used.
By applying both denominators, a better understanding
of the temporal trends in antibiotic use can be gained
[3-5].
Second, the World Health Organisation (WHO)-de-
rived system of defined daily doses (DDDs), although
internationally accepted as units of measurement for
drug utilization, is not always suitable for showinghis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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doses may differ from the recommended antibiotic doses
or the doses that are actually prescribed [6,7]. Alternative
units have been considered [8,9]. In a recent study, we
found a marked difference between WHO defined doses
(WHO DDDs) and doses recommended in hospital guide-
lines, especially for the penicillins [10]. The discrepancy
had consequences for the interpretation of the data on
antibiotic use and we suggested that WHO DDDs should
be supplemented with hospital-adjusted defined daily
doses (haDDDs) in the surveillance of antibiotic use.
A further challenge in surveillance methodology is to
identify factors that affect the use of antibiotics in hospi-
tals. Few studies have addressed this issue. The aim of
the present study was to investigate, by use of a national
surveillance data set, the extent to which relevant, vali-
dated hospital- and patient-related variables can explain
differences in antibiotic use.
Methods
Study hospitals (Health Enterprises, HEs)
We registered data on antibiotic use in the period from
2006 to 2011 (six years) for the 19 public HEs (five
university-affiliated and 14 large general HEs) and three
large private HEs in Norway. Each public HE consists of
one to seven hospital units and covers a complete and
comparable spectrum of specialties, except specialized
units for transplantation, heart surgery, neurosurgery,
burns and multitrauma that are established only at the
university hospitals. The three private institutions in-
clude mainly general internal medicine and surgery and
intensive care units. We excluded four private institu-
tions with specialized functions for elective orthopaedics
and rheumatology, cardiac surgery and rehabilitation, and
all psychiatric and drug abuse institutions.
Ideally, analyses of antibiotic use should be performed
at the level of hospital units, and the distribution of
clinical specialties within each hospital should be known.
However, at present administrative and clinical data of
this kind are not routinely available from official and val-
idated national sources. The lowest level at which this
information may be acquired is the HE. Consequently,
data on antibiotic use were analysed for whole HEs.
Antibiotic use
We have previously reported the method for antibiotic
data acquisition [10]. Briefly, we acquired data on hos-
pital antibiotic use from a national pharmacy database.
The data set was processed in a Microsoft Excel spread-
sheet and further analysed in the statistical program
Stata version 12 (StataCorp LP, College Station, TX). All
systemic antibacterial agents except methenamine in-
cluded in the Anatomical Therapeutic Chemical (ATC)
DDD group J01 were registered. From other ATC DDDgroups, we included oral vancomycin, rifampicin and
oral metronidazole.
Data on antibiotic use was expressed in DDDs using the
2011 WHO ATC/DDD classification [11]. DDDs were
related to length of stay, which was measured in BDs, de-
fined as the date of discharge minus the admission date.
The number of patient discharges was used as an add-
itional denominator for measure of antibiotic use [12].
In a previous study, we adjusted the WHO DDDs for a
number of antibiotic substances [10]. These DDDs, des-
ignated haDDDs, were based on dose recommendations
outlined in regional and national antibiotic guidelines
[13]. The same haDDD values supplemented the WHO
DDDs in the current study.
Dependent (outcome) variables
Total antibiotic use (“all antibiotics”) in the period 2006
to 2011 for the 22 HEs was the main dependent variable
in the regression analyses. We also designated two sub-
groups as dependent variables: use of “broad-spectrum
antibiotics” (second- and third-generation cephalosporins,
fluoroquinolones, carbapenems, and penicillins with en-
zyme inhibitors) and use of “all penicillins” (penicillinase
sensitive, penicillinase resistant and extended-spectrum
penicillins). Each of these three antibiotic groups was ana-
lysed using the following measurement units: DDD/100
BDs, DDD/100 discharges, haDDD/100 BDs and haDDD/
100 discharges.
Independent variables
Administrative data and candidate explanatory variables
for each HE were derived from publicly available on-line
databases maintained by Statistics Norway [14]. For the
regression analyses, we included independent variables
that were considered clinically plausible and thus possibly
associated with antibiotic use. Moreover, we required the
variables to be clearly defined, quality assessed by a recog-
nized national body, and easily accessible. These require-
ments were set to establish a reproducible, robust data set
of optimal quality.
The 11 continuous variables (Table 1) were: per cent
of hospital stays lasting < 2 days, per cent of hospital
stays lasting > 10 days, number of physicians per 100
hospital beds, number of registered nurses per 100 hos-
pital beds, per cent of discharges with a cancer ICD-10
main diagnosis, per cent of discharges with an infectious
diseases ICD-10 main diagnosis, per cent of discharges
with a surgical main diagnosis-related group (DRG), per
cent of discharges with a medical main DRG, number of
day care treatments, number of ambulatory consultations
for all patients and number of ambulatory consultations
for patients with infectious diseases (the last three vari-
ables measured per 100 hospital beds). The variables for
day care and ambulatory patients were included because
Table 1 Measurement units and value ranges for continuous variables entered into 12 linear regression models
Continuous variables Unit Data pointa range Mean
Hospital stay < 2 days % of discharges 24.5–40.5 32.4
Hospital stay > 10 days % of discharges 5.2–17.3 9.7
Number of physiciansb per 100 hospital beds 38.8–128.3 63.9
Number of nurses per 100 hospital beds 132.5–300.1 197.6
IDc main ICD-10 diagnosis % of discharges 1.6–6.0 2.9
Cancer main ICD-10 diagnosisb % of discharges 3.6–17.1 8.0
Surgical DRGs % of discharges 18.0–39.8 27.5
Medical DRGsb % of discharges 46.4–79.6 65.9
All ambulatory consultationsb per 100 hospital beds 89.9–543.3 327.6
IDc ambulatory consultationsd per 100 hospital beds 0.5–7.7 2.7
Day-care treatmentsd per 100 hospital beds 10.1–79.5 35.9
a132 data points: six years of 22 Health Enterprise's annual data.
bVariable removed from the regression models due to collinearity.
cID: (any) infectious diseases.
dVariable included in model, but not significantly associated with antibiotic use.
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stock as the in-patients.
Three categorical independent variables were also inclu-
ded (Table 2). These were university versus non-university
affiliation, size of the HE (<300 hospital beds, 300–600
beds and > 600 beds) and geographical region (i.e. belong-
ing to one of four Norwegian Health Regions).
All HEs used the same DRG version based on the
WHO ICD-10 classification (NordDRG, version NOR
PR1) during the study period. A surgical main DRG de-
notes a hospital stay during which a procedure was perfor-
med in an operating theatre. A medical main DRG was
registered when no such procedure took place.
Statistical analyses
Collection of the annual data on antibiotic use for 22
HEs over six years resulted in data sets containing 132Table 2 Description of three categorical variablesa
entered into 12 linear regression models
Variables
(No. of data points)
% of
beds
% of
bed days
% of
discharges
Average HE
stay (d)
University HEsb (30) 40.6 40.7 38.5 4.9
Non-university HEs (102) 59.4 59.3 61.5 4.5
Health Region 1 (60) 54.0 54.2 55.5 4.5
Health Region 2 (30) 20.3 20.8 20.5 4.7
Health Region 3 (18) 14.3 14.5 13.8 4.8
Health Region 4 (24) 11.4 10.4 10.2 4.7
HEs < 300 beds (35) 9.0 8.6 8.3 4.8
HEs 300–600 beds (50) 31.0 31.7 33.3 4.4
HEs > 600 beds (47) 60.0 59.7 58.5 4.7
132 data points (22 HEsb over 6 years) for each independent variable.
aOf the three categorical variables, only university affiliation was independently
associated with antibiotic use in eight of the 12 regression models.
bHE = Health Enterprise.observations. Analyses were done with Stata statistical
software version 12 (StataCorp LP, College Station, TX).
For correlations between continuous variables, Pearson
correlations (Stata procedure: 'pwcorr') was used. Since
our data were normally distributed and the dependent
variables continuous, we analysed 12 different multiple
linear regression models (procedure: 'regress'). The same
14 independent variables were introduced in all regression
models.
To account for possible dependence of observations
within the individual HEs, that is to say dependence re-
lated to repeated and possibly correlated annual measures
for the 22 HEs, we performed robust linear regression
analyses with HEs as clusters (variance estimator option
'cluster').
In a stepwise approach, a test for collinearity of the
independent variables (i.e. the extent to which the
variables are related to each other) was performed to
fit the final model. We used the variance inflation factor
(vif ) which tests for multivariate multicollinearity (pro-
cedure: 'estat vif'). In each regression step, the variable
was excluded that had the highest vif, i.e. for which the
least amount of its variance was associated with the
outcome. This was repeated until no variable had a
vif > 5 [15].
Because of a relatively large number of independent
variables, the adjusted R square (aR2) was calculated for
each regression model to show how well it fitted the
data. For all analyses, aR2 > 0.3 was considered a strong
correlation. A two-tailed P-value < 0.05 was set as a limit
for statistical significance. To assess the unique contri-
bution of each independent variable to the increment in
aR2 in the final models, a conservative semi-partial R2
was calculated for each variable using Stata procedure
'pcorr' [15].
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All antibiotic and broad-spectrum antibiotic use
From 2006 to 2011, the mean annual use, measured by
WHO DDDs per 100 bed days, increased for “all antibi-
otics” from 62.7 to 73.0 and for “broad-spectrum antibi-
otics” (BSAs) from 15.4 to 18.7 (Figure 1). For each year
a lower level was registered for university HEs than for
non-university HEs, all specialties combined, with regard
to both all antibiotic use and BSA use. However, for BSA
use this difference diminished during the study period.
For all antibiotic use and BSA use related to number of
discharges no significant increases were found during
the period (data not shown).
Multivariate regression analyses
Fourteen independent variables were entered into the
multiple linear regression models, of which four were re-
moved from the analyses because of collinearity: medical
DRGs, infectious diseases ambulatory consultations, can-
cer main ICD-10 diagnosis, and number of physicians.
Of the remaining ten variables that were included in the
models, six were found to be independently and signifi-
cantly correlated with antibiotic use. A correlation was
found for between two and five of these six variables
depending on the outcome measure, i.e. one of the 12
combinations of antibiotic group and units of measure-
ment (Tables 3 and 4).
We found that for all regression models, except for
BSA use measured in WHO DDDs and haDDDs per 100
discharges, the aR2 equalled or significantly exceeded
0.3, which indicates that the overall models fitted the
data well [15].
Hospital characteristics and geographical area
Of the three categorical variables (Table 2), only a univer-
sity affiliation of the HE was independently associated
with antibiotic use (Tables 3 and 4). A university affiliationFigure 1 All antibiotic and broad-spectrum antibiotic use in 22 Norwe
averages for all HEs and according to university affiliation of HEs.of the HE was strongly and negatively correlated with the
use of all antibiotics and use of BSAs, both when BDs and
discharges were used as denominator. No significant dif-
ference was found between university and non-university
HEs with regard to penicillin use. The lower level of
utilization in university HEs, measured in WHO DDDs/
100 BDs, amounted to −11.8 for all antibiotics and −2.7
for BSAs (Table 3). University HE status strongly af-
fected the results by exhibiting a high unique explana-
tory strength (4%–13%), particularly with the use of BDs
as denominator.
Physician and nurse staffing and the length of hospital stay
The variable describing the rate of physicians per hos-
pital bed was found redundant in the regression analyses
because of collinearity. By contrast, a change in the
number of nurses per hospital bed correlated positively
and strongly with all antibiotic use and all penicillin use,
demonstrated by all four measurement units, but only
marginally with BSA use measured with haDDDs. One
unit change between HEs of nurse staffing rate (inter-
HE range, 167.6 nurses/100 hospital beds, Table 2) was
independently associated with a difference of 0.17 DDDs/
100 BDs for all antibiotics and of 0.1 DDDs/100 BDs for
all penicillins (Table 3).
A positive and moderate to strong correlation with
antibiotic use was found for the two variables character-
izing the length of hospital stay. The proportion of hos-
pital stays of < 2 days was significantly correlated with
increased antibiotic use in relation to 100 BDs (Table 3).
In particular, the percentage of short hospital stays cor-
related strongly with high BSA use both for DDDs and
for haDDDs, and the variable contributed 7% and 8% to
the observed variances in the two models, respectively.
A change of 1% in the proportion of short hospital
stays resulted in a dose change of 0.3 for both indices. A
high proportion of hospital stays > 10 days correlatedgian Health Enterprises (HEs), 2006 – 2011. Annual utilization
Table 3 Explanatory factors significantly related to antibiotic use (number of bed days as denominator) in Norwegian Health Enterprises, 2006–2011, derived
from six multiple linear regression models
Independent variables WHO DDDs/100 bed days Hospital-adjusted DDDs/100 bed days
All antibiotics Broad-spectruma All penicillinsb All antibiotics Broad-spectruma All penicillinsb
Overall model, R2 (adjusted R2) 0.49 (0.43) 0.40 (0.33) 0.55 (0.50) 0.43 (0.37) 0.36 (0.30) 0.59 (0.54)
Infect. disease ICD-10 main diag. (%)
Regression coeff. (95% C.I.) 5.35*** (2.33; 8.38) 3.83*** (1.34; 6.33) 2.86** (1.00; 4.71) 1.56** (0.59; 2.54)
Beta weight 0.47 0.45 0.41 0.44
Increment in R2 0.0690 0.0633 0.0509 0.0606
Registered nurses per 100 beds
Regression coeff. (95% C.I.) 0.17*** (0.08; 0.26) 0.10*** (0.04; 0.15) 0.10** (0.04; 0.17) 0.02* (0.001; 0.04) 0.04** (0.02; 0.06)
Beta weight 0.56 0.44 0.57 0.28 0.39
Increment in R2 0.1141 0.0706 0.1163 0.0293 0.0548
Hospital stay < 2 days (%)
Regression coeff. (95% confidence interval (C.I.)) 0.81* (0.04; 1.57) 0.31* (0.05; 0.58) 0.29* (0.04; 0.53)
Beta weight 0.29 0.38 0.40
Increment in R2 0.0422 0.0718 0.0829
University hospital (binary)
Regression coeff. (95% C.I.) −11.82** (−20.5; −3.2) −2.65*** (−4.01; −1.29) −8.22*** (−12.3; −4.1) −2.72*** (−3.53; −1.91)
Beta weight −0.55 −0.41 −0.62 −0.49
Increment in R2 0.1078 0.0607 0.1354 0.0868
Surgical DRGsc per 100 beds
Regression coeff. (95% C.I.) 0.15* (0.01; 0.30) 0.52* (0.06; 0.97)
Beta weight 0.29 0.48
Increment in R2 0.0222 0.0589
Significance levels: *P < 0.05, **P < 0.01, ***P < 0.001.
aBroad-spectrum antibiotics: second- and third-generation cephalosporins, fluoroquinolones, carbapenems, and penicillins with enzyme inhibitors.
bAll penicillins: penicillinase sensitive, penicillinase resistant and extended-spectrum penicillins.
cDRG: Diagnosis-related groups.
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Table 4 Explanatory factors related to antibiotic use (number of discharges as denominator) in 22 Norwegian Health Enterprises, 2006–2011, derived from six
multiple linear regression models
Independent variables WHO DDDs/100 discharges Hospital-adjusted DDDs/100 discharges
All antibiotics Broad-spectruma All penicillinsb All antibiotics Broad-spectruma All penicillinsb
Overall model, R2 (adjusted R2) 0.71 (0.67) 0.30 (0.22) 0.68 (0.65) 0.71 (0.68) 0.34 (0.26) 0.72 (0.69)
Infect. disease ICD-10 main diag. (%)
Regression coeff. (95% confidence interval (C.I.)) 30.6*** (15.9; 45.2) 21.9*** (10.0; 33.8) 16.4*** (7.5; 25.4) 8.95*** (4.3; 13.6)
Beta weight 0.44 0.45 0.36 0.44
Increment in R2 0.0588 0.0614 0.0406 0.0591
Registered nurses per 100 beds
Regression coeff. (95% C.I.) 0.78*** (0.37; 1.20) 0.46*** (0.21; 0.72) 0.49*** (0.21; 0.77) 0.17** (0.07; 0.27)
Beta weight 0.43 0.36 0.42 0.43
Increment in R2 0.0657 0.0463 0.0625 0.0357
Hospital stay > 10 days (%)
Regression coeff. (95% (C.I.) 12.1** (5.1; 19.2) 2.38** (0.9; 3.86) 7.46* (1.2; 13.7) 8.27*** (4.4; 12.2) 2.75** (1.2; 4.3) 2.99*** (0.4; 5.6)
Beta weight 0.48 0.45 0.42 0.51 0.56 0.41
Increment in R2 0.0861 0.0753 0.0663 0.0956 0.1157 0.0616
University hospital (binary)
Regression coeff. (95% C.I.) −47.6*** (−84.6; −10.7) −9.8** (−15.5; −4.1) −33.6*** (−51.1; −16.2) −10.9*** (−14.5; −7.2)
Beta weight −0.36 −0.35 −0.39 −0.42
Increment in R2 0.0458 0.0441 0.0545 0.0626
Surgical DRGsc per 100 beds
Regression coeff. (95% C.I.) 2.43* (0.2; 4.6)
Beta weight 0.35
Increment in R2 0.0316
Significance levels: *P < 0.05, **P < 0.01, ***P < 0.001.
aBroad-spectrum antibiotics: second- and third-generation cephalosporins, fluoroquinolones, carbapenems, and penicillins with enzyme inhibitors.
bAll penicillins: penicillinase sensitive, penicillinase resistant and extended-spectrum penicillins.
cDRG: Diagnosis-related groups.
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using number of discharges as the denominator (Table 4).
This variable contributed significantly to the observed var-
iances in these models, particularly for BSA use where the
explanatory strength was as high as 8% and 12% for WHO
DDDs and haDDDs, respectively.Diagnosis-related variables
Two variables related to the medical condition of the
patients were correlated with antibiotic use. The propor-
tion of patient hospital stays with an infectious disease
main ICD-10 diagnosis was highly significant (P <0.01)
and strongly correlated (beta weights of 0.36 to 0.47)
with all antibiotic use and with the use of penicillins, but
not with BSA use. One percent change in the proportion
of ICD-10 infectious diseases main diagnosis was associ-
ated with a difference between two HEs in all antibiotic
use of 5.35 DDDs/100 BDs and in penicillin use of 3.83
DDDs/100 BDs (see regression coefficients, Table 3).
However, the interpretation of this finding should take
into consideration that the interval of the observed data
range was only 4.4% (Table 1), i.e. the range of unit dif-
ferences between HEs for this explanatory variable was
narrow. Also of note, ICD-10 infectious diseases main
diagnosis contributed uniquely to 4%–7% of the obser-
ved variances in the eight models (increments in R2).
The proportion of hospital stays with surgical DRGs
contributed 6% and 3% to the overall variances in the
models for all antibiotics use, measured with haDDDs
per 100 BDs and per 100 discharges, respectively. The
proportion of surgical DRGs varied between HEs with
an interval of 21.8% (Table 2) and each percentage dif-
ference between two HEs was associated with a change
in all antibiotic use of 0.15 haDDDs/100 BDs and 0.51
haDDDs/100 discharges.Discussion
An increase in all antibiotic use and BSA use observed
during the six-year study period has been reported in
more detail [10]. We have also previously, by use of an-
other data set, reported sizeable differences in antibiotic
use between various Norwegian HEs [16].
In the present study, we identified several factors that
were associated with dissimilarities in antibiotic use
between HEs in Norway. High levels of nurse staffing, a
high proportion of hospital stays with an infectious dis-
ease main ICD-10 diagnosis or a principal surgical DRG,
and high proportions of short or long hospital stays were
associated with increased antibiotic use. On the contrary,
university affiliation was strongly associated with lower
antibiotic use. The other hospital-associated variables—
hospital size and geographical location—were not corre-
lated with the levels of antibiotic use.A main finding was the robustness that these variables
exhibited across all models. Regardless of the measure-
ment unit, with few exceptions the same explanatory
variables were significantly related to antibiotic use within
each of the three outcome (antibiotic) groups. Thus, in
our opinion, the variables are valid for the evaluation of
antibiotic surveillance results when different units of mea-
surements are applied [9,11].
Our finding that the university HEs had significantly
lower consumption of antibiotics than non-university hos-
pitals in all models may seem surprising. For example, it
contrasts the result of a German study of 145 acute care
hospitals where regional variances in all antibiotic use
were investigated [17]. Regional variances were not identi-
fied, but higher levels of use correlated significantly with
hospital university affiliation. However, the German study
did not include all specialties of the university hospitals
but targeted only high-consumption units (surgical and
internal medical wards, intensive care and haematology/
oncology units). Contrary to this, our analyses were done
on whole HEs because administrative data on the level of
medical specialties were not available for the period in
question.
The most probable explanation for the discrepancy
is the relatively large subset in our university hospi-
tals of units with a low usage of antibiotics, such as
maternity/obstetric units, rehabilitation wards and paedi-
atric specialties.
In support of this view is an additional analysis, which
we undertook of a published data set for the period
2002–2007 [16]; this data set contained information
about the various specialties. We found that the propor-
tion of bed days in core units, out of all HE bed days,
were significantly lower in university hospitals than in
non-university hospitals (64% versus 79%; other data of
the analysis not shown here). Furthermore, the use of
antibiotics in core units was similar in university and
non-university hospitals. Also, the antibiotic utilization
level was almost four-fold higher in core units than in
other units.
A French study also lends support to the explanation
above [18]. In a study of 77 public hospitals, it was
found that the relative number of patient days spent in
internal medicine, surgical and intensive care units could
explain most of the variability in antibiotic utilization.
The authors concluded that there is a need to establish
country-specific factors to aid interpretation of surveil-
lance results. This is in accordance with our view that
separate analyses should be carried out for university
and non-university institutions.
Our finding of a strong positive correlation between
high levels of nurse staffing and antibiotic use does not
imply a causal relationship, but rather that high nurse
ratios may be a surrogate marker for high proportions of
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is related to higher levels of intensive care and more
patients with complicated medical conditions.
Both shorter stays (<2 days) and longer stays (>10 days)
were strongly associated with increased BSA use. It ap-
pears that the proportion of short hospital stays should
be used as an adjustment factor when interpreting sur-
veillance results using number of BDs as the denomin-
ator. By contrast, longer stays have an impact on the
results when the number of discharges is the denomin-
ator. A possible explanation for the positive correlation
between short stays and BSA use may be more extensive
empiric antibiotic treatment on hospital admission, be-
fore culture results and other diagnostic results are avail-
able. The correlation to prolonged hospital stays may be
explained by more frequent BSA use in patients treated
for complicated conditions. That short hospital stays are
linked to extensive utilization of antibiotics is consistent
with the finding in an Israeli study where one-day hos-
pitalizations were associated with high consumption of
antibiotics [20].
The strong relationship between an infectious disease
main ICD-10 diagnosis and all antibiotic and all penicil-
lin use is plausible. The reason why this variable showed
no independent association with BSA use may be related
to a sparse data set, as use of BSAs in Norwegian hospi-
tals, although exhibiting an alarming increase, is still
limited [16]. In addition, in severely ill patients for whom
BSAs are extensively used, a serious underlying condition
rather than the superimposed infections tends to be regis-
tered as the main diagnosis.
A positive correlation between all antibiotic use and
surgical DRGs may reflect a high consumption of antibi-
otics for preoperative prophylaxis and for treatment of
postoperative infections. The finding that surgical ser-
vices were associated with higher antibiotic use than
medical services may seem unexpected since the latter
are often considered more antibiotic-intensive units. How-
ever, this opinion could be challenged. Of note, a strong
association was only found when haDDDs was applied,
not with the use of WHO DDDs. In a previous study, we
have shown that the use of haDDDs reflects hospital
prescription recommendations better than WHO DDDs.
Among other things, an underestimation of the propor-
tion of metronidazole, cefalotin and doxycycline use,
which appears when WHO DDDs are applied, is abro-
gated with use of haDDD. These drugs are used exten-
sively – and cefalotin almost exclusively – for surgical
prophylaxis in Norwegian hospitals [10,13]. Accordingly,
more nuances are needed when comparing medical and
surgical departments.
The lack of data on the distribution of medical special-
ties within the various HEs may be considered a limita-
tion of our study. To request these administrative datafrom each HE would be a task not compatible with a
routine national surveillance and, moreover, doubts
might be raised with regard to the quality of locally ob-
tained data. In addition, a correct allocation of patients
to their specialties merely based on the wards designa-
tion is made difficult because of increasingly complex
internal logistics in hospitals, mainly resulting from space
limitations and task sharing between departments. How-
ever, in the future antibiotic data may be more reliantly
linked to specialties through electronic prescribing mod-
ules integrated in patient-administrative systems.
Another potential limitation is the fact that we were
not in possession of any specific parameter defining the
severity of illness. A main challenge in the benchmark-
ing of hospital performance, including the use of antibi-
otics, is to adjust for patient case-mix [21]. However, to
date no case-mix model has been generally and unani-
mously endorsed. Moreover, certain limitations are present
in studies investigating case-mix for limited time periods
[22] or case-mix based on repeated prevalence surveys
[23]. It should also be noted that the longitudinal studies
discussed above [18,20] examined specific clinical variables
and morbidity indices, such as the Charlson score [24],
but none were found to be independently correlated with
antibiotic use.
Finally, we have not considered any hospital data on
antibiotic resistance. On a national scale, antibiotic resist-
ance in hospital- or community-acquired pathogens is
unlikely to be a major determinant for differences in anti-
biotic use. The reason for this is that the prevalence of
resistance in Norwegian hospitals remains low [16,25].
A particular strength of our study is the inclusion of
all Norwegian hospitals and the long observation period
of six years. In addition, the independent variables investi-
gated were based on official information from validated
and easily available national sources, which makes them
applicable for a routine surveillance system. To our know-
ledge, this is the first study to apply this kind of data set.
Furthermore, with regard to the statistical analyses
we assessed the possible non-independence of repea-
ted measures within HEs. The possibility of such non-
independence made us introduce HEs as clusters in the
regression models. However, the results obtained by use of
this robust model were largely the same as those
found with a standard multiple regression technique
(data not shown).
Other outcome variables related to antibiotic utilization,
for example health-care associated infections [26-28] and
antibiotic-resistant infections [29], have been investigated
for the purpose of adjusting for inter-hospital differences.
Probably, these methods may be applicable also for bench-
marking of hospital antibiotic use.
Although the factors identified in our study contributed
substantially to differences in utilization of antibiotics in
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50% for all antibiotic use and 60%–70% for BSA use) that
cannot be explained by these factors. Of these non-
identified factors, attitudes and personal preferences of
leading prescribing physicians are probably of special rele-
vance [30]. Medical culture in general, levels of education,
whether or not guidelines exist, and where they do, their
content and quality, are elements that should be consid-
ered. Particular attention should be given to the use of
BSAs because their use may lead to the development of
resistant microbes. There is a need for heightened aware-
ness with regard to the consequences of untoward use of
these antibiotics.
Almost none of the explanatory factors demonstrated
in this study are modifiable through interventions by
health care workers or hospital administrators. However,
it is crucial to reveal inappropriate antibiotic use and to
establish prudent prescription behaviour [31,32]. Know-
ledge about existing non-modifiable conditions provides
a much-needed in-depth understanding of antibiotic
surveillance results. With this background knowledge, it
becomes easier to identify which findings are related to
inappropriate prescribing practices.
Conclusions
While several strategies may be used to achieve a pru-
dent use of antibiotics in hospitals [33], one initial step
should be to identify the factors that are not prescriber
related. Adjustments for non-modifiable factors, such as
the ones we have established, may increase the confi-
dence in observed surveillance results. This method thus
enables us to better identify and target explicit areas for
intervention measures.
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